Biography
Dr Yoni Byron is a medical oncologist committed to delivering evidence-based, patient-centred care. He values clear communication, multidisciplinary collaboration and supporting patients throughout their treatment journey. Dr Byron has experience across metropolitan, regional and remote healthcare settings, with clinical interests in gastrointestinal, genitourinary, brain and spine (CNS), skin and head and neck cancers.
Dr Byron graduated from the University of Tasmania in 2014 and commenced his training at the Royal Hobart Hospital before relocating to New South Wales to continue specialist oncology training. His final year of training, undertaken at Central Coast NSW alongside Dr Wong and Associate Professor Back, provided further experience in the management of central nervous system and upper gastrointestinal malignancies.
Dr Byron’s first consultant post was at Royal Darwin Hospital, where he developed experience in tropical and Indigenous health. During his time in Darwin, he was co-chair of the clinical trials unit and teaching coordinator for the Division of Medicine at Flinders University.
In 2025, following the birth of his first child, Dr Byron returned to Tasmania to be closer to family. He remains passionate about research, clinical trials and teaching medical students and junior doctors. He is actively involved in training medical oncology advanced trainees and is an Adjunct Senior Lecturer at Flinders University and an Adjunct Research Fellow at Charles Darwin University.
Dr Byron accepts referrals for all cancer types, with particular clinical interests in upper gastrointestinal cancers (including neuroendocrine, hepatobiliary and pancreatic malignancies), lower gastrointestinal cancers, genitourinary cancers (including prostate cancer), brain and spine (CNS) tumours, skin cancers (including melanoma), and head and neck cancers.
He is also experienced in the management of breast, lung and gynaecological cancers and is available to support the care of sarcoma patients.
Publications
Byron Y, Yegorova-Lee S, Tio M. Do corticosteroids affect immunotherapy efficacy in malignancy? Cancer Medicine. 2024;13(18):e70254.
Byron Y, Yegorova-Lee S, Tio M. Do corticosteroids affect immunotherapy efficacy in malignancy? Journal of Clinical Oncology. 2023;41(16_suppl):e14692.
Byron Y, Nott L, Shackleton M. Acute tumour lysis syndrome following encorafenib and binimetinib in V600E metastatic melanoma. Melanoma Research. 2020;30(6):625–627.
Byron Y, West H, Wood B, Murray L, Cooling N. Effectiveness of student-run organizations in global health promotion. Global Health Promotion. 2015;22(3):55–58.